Ingredients:
Serenoa Repens (Saw Palmetto Extract), Pygeum Africanum, OptiZinc, Capsicum,
DL-Methionine, L-Aspartic Acid, L-Glutamic Acid, L-Alanine, L-Glycine,
Pyridoxine HCL-B6, Vitamin E (mixed tocopherols), Oil of Evening Primrose,
Damiana, Ho-Shou-Wu, Siberian Ginseng, Magnesium (from Aspartate), Micro-Nutritionals:,
Adulaire, Auriferous chalcopyrite, Ammonium muriaticum, Chimaphila umbellata,
Conium maculatum, Ferrum picricum, Staphysagria,Thuja occidentalis.
Benign Prostatic Hyperplasia is thought to occur when
accumulated testosterone in the prostate is converted to dihydrotestosterone,
stimulating cells to multiply excessively and causing the prostate to
enlarge. Clinical studies have shown that when 5-a-reductase is inhibited
within the body, testosterone will not be converted to dihydrotestosterone,
and the prostate generally atrophies, subsequently deobstructing the urethra
for easier urinary flow...
Prostatin+ is a Scientifically Advanced Endocrinal
Nutraceutical Dietary Supplement which may safely complement your
physician's recommended protocol, providing essential phytomedicinal and
nutritional support for the Prostate gland, and especially for those
suffering from mild to moderate Benign Prostatic Hyperlasia (BPH), where
dysfunction may lead to inappropriate enlargements and swellings of the
Prostate which often proves painful and incapacitating regarding the
abilities to pass urine, frequent micturation at night, as well as to
perform normally regarding sexual function. With the extra specific
nutrients and proper nutritional regime, the body often has the ability to
heal itself more quickly, even with problems of this type.
The Specific Nutraceuticals used in Prostatin+ have
been well documented regarding their efficacy of BPH symptomology and
relief. Scientists have found that Saw Palmetto can be used as a primary
treatment for both short-term and long-term treatment of BPH, with little
or no side effects as compared to synthetic pharmaceuticals.
BPH is thought to occur when accumulated
testosterone in the prostate is converted to dihydrotestosterone,
stimulating cells to multiply excessively and causing the prostate to
enlarge. Clinical studies have shown that when a steroidal enzyme called
5-a-reductase is inhibited, the hormone testosterone will not be converted
within the prostate to dihydrotestosterone, and the prostate generally
atrophies (shrinks glandular hyperplasia), subsequently deobstructing the
urethra for easier urinary flow, and thereafter preventing the development
of incontinence because of exhaustive bladder failure. Saw palmetto
appears to inhibit 5-a-reductase and offer anti-edematous actions.
In a conservative study that used lower dosages of
Saw Palmetto and Nettle than can be found in Prostatin+, over a 12 week
period patients reported a 25.8% increase in maximum urinary flow, a 29.0%
increase in mean urinary flow, a 44.7% reduction in residual urine, a
50.4% reduction in nocturia, a 62.5% reduction in dysuria and a 53.6%
reduction in post-void dribbling. Interestingly, most popular conventional
pharmaceuticals used for BPH, whether for inhibiting hormones or
a-adrenergic blockers (smooth muscle relaxers), often demonstrate little
change within the first six months of therapy.
Moreover, Saw Palmetto is also a research candidate
as a potential deterrent to prostate cancer. Also, Taxus Brevifolia (the
Pacific Yew Tree), yet another ingredient in Prostatin+, contains "taxol"
which has demonstrated high cytotoxic effect on prostatic cancer cells, or
in other words, has been found to be phytomedicinally active against
prostate cancer.
